LENZ Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for LENZ Therapeutics (LENZ).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$29Upside to Avg. PT+839.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$38→$16
Oct 29, 2026	TD Cowen	Stacy Ku	PT Cut	Buy	$50→$45
Oct 21, 2026	TD Cowen	Stacy Ku	PT Cut	Buy	$60→$50
Oct 19, 2026	Piper Sandler	Biren Amin	PT Cut	Neutral	$7→$5
Aug 12, 2026	Piper Sandler	Biren Amin	PT Cut	Neutral	$12→$7
Jul 7, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$38
May 13, 2026	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$26→$20
May 12, 2026	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$48→$38
May 12, 2026	Piper Sandler	Biren Amin	Downgrade	Overweight→Neutral	$39→$12
Apr 21, 2026	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$56→$48
Mar 26, 2026	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$52→$26
Mar 25, 2026	B of A Securities	Jason Gerberry	PT Cut	Buy	$35→$29
Oct 20, 2025	Raymond James	Gary Nachman	PT Raise	Outperform	$40→$50
Oct 10, 2025	Piper Sandler	Biren Amin	PT Raise	Overweight	$51→$67
Aug 1, 2025	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$49→$52
Aug 1, 2025	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$48→$56
Jul 31, 2025	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$45→$49
Jul 31, 2025	Raymond James	Gary Nachman	PT Raise	Outperform	$39→$40
Jul 28, 2025	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$38→$48
May 8, 2025	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$38

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on LENZ Therapeutics, Lowers Price Target to $16

HC Wainwright & Co. analyst Matthew Caufield maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and lowers the price target from $38 to $16.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $45

TD Cowen analyst Stacy Ku maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and lowers the price target from $50 to $45.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $50

TD Cowen analyst Stacy Ku maintains LENZ Therapeutics (NASDAQ:LENZ) with a Buy and lowers the price target from $60 to $50.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5

Piper Sandler analyst Biren Amin maintains LENZ Therapeutics (NASDAQ:LENZ) with a Neutral and lowers the price target from $7 to $5.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7

Piper Sandler analyst Biren Amin maintains LENZ Therapeutics (NASDAQ:LENZ) with a Neutral and lowers the price target from $12 to $7.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on LENZ Therapeutics, Maintains $38 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates LENZ Therapeutics (NASDAQ:LENZ) with a Buy and maintains $38 price target.

Benzinga Newsdesk

LENZ Therapeutics Inc

LENZ Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on LENZ Therapeutics, Lowers Price Target to $16

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $45

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $50

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7

PRO
HC Wainwright & Co. Reiterates Buy on LENZ Therapeutics, Maintains $38 Price Target

People Also Watch

People Also Watch

LENZ Therapeutics Inc

LENZ Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on LENZ Therapeutics, Lowers Price Target to $16

PROTD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $45

PROTD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $50

PROPiper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5

PROPiper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7

PROHC Wainwright & Co. Reiterates Buy on LENZ Therapeutics, Maintains $38 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on LENZ Therapeutics, Lowers Price Target to $16

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $45

PRO
TD Cowen Maintains Buy on LENZ Therapeutics, Lowers Price Target to $50

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $5

PRO
Piper Sandler Maintains Neutral on LENZ Therapeutics, Lowers Price Target to $7

PRO
HC Wainwright & Co. Reiterates Buy on LENZ Therapeutics, Maintains $38 Price Target